$203.87
Price
$29.6B
Market Cap
19.6
P/E Ratio
16.9
Forward P/E
$10.38
EPS (TTM)
1.15%
Dividend Yield
$1.7B
Cash
$852M
Total Debt
145M
Shares Out
$180.27
$293.81
52-Week Range
Institutional Ownership of RESMED INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Giverny Capital|Francois Rochon
|
230.0K | $52M | $273.81 | -5.93% |
Trading Activity for RESMED INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -2.3% | 230.0K | $52M | $253.93 | |
| 2025-Q4 | |||||
| SELL | -0.0% | 235.4K | $57M | $252.11 | |
| 2025-Q3 | |||||
| BUY | NEW | 235.4K | $64M | $273.81 | |
| 2023-Q4 | |||||
| SELL | EXIT | — | — | $150.41 | |
| 2023-Q3 | |||||
| SELL | -49.2% | 11.7K | $2M | $173.71 | |
| 2023-Q2 | |||||
| BUY | +17.5% | 23.1K | $5M | $222.18 | |
| SELL | EXIT | — | — | $222.18 | |
| 2023-Q1 | |||||
| BUY | +12.5% | 19.6K | $4M | $214.63 | |
| 2022-Q4 | |||||
| SELL | -4.2% | 17.5K | $4M | $220.86 | |
| 2022-Q2 | |||||
| BUY | +17.4% | 18.2K | $4M | $208.30 | |
| 2022-Q1 | |||||
| BUY | +95.2% | 15.5K | $4M | $241.05 | |
| 2021-Q4 | |||||
| BUY | NEW | 8.0K | $2M | $260.30 | |
| 2021-Q1 | |||||
| SELL | EXIT | — | — | $200.25 | |
| 2020-Q4 | |||||
| BUY | NEW | 356.3K | $76M | $209.21 | |
| 2020-Q3 | |||||
| BUY | NEW | 437 | $75000 | $180.68 | |
Insider Trading for RESMED INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.